Connect your AI

Perspective Therapeutics CATX Price / book

Price / book at other companies

Eli LillyLLY

26.3×-20.7×

CytomX TherapeuticsCTMX

3.2×+1.1×

Monopar TherapeuticsMNPR

2.7×-1.4×

ImmunomeIMNM

4.2×+2.3×

Viridian Therapeutics, Inc.VRDN

3.1×+1.3×

Lantheus HoldingsLNTH

4.1×-1.7×

Other financials

Income statement

Revenue$2.2M+27.3%

Gross profit$738.0K+78.3%

Operating income-$28.3M-29.5%

Net income-$26.2M-44.1%

EPS (diluted)-$0.250.0%

Balance sheet

Cash & equivalents$54.0M+21.5%

Total debt$4.2M+10.9%

Total equity$347.4M+22.1%

Total assets$410.8M+24.7%

Cash flow

Operating cash flow-$31.5M-45.8%

CapEx$6.9M+47.3%

Free cash flow-$38.3M-46.1%

Valuation

Market cap$342.14M+33.2%

Enterprise value$292.34M+35.2%

P/S34.2×+19.6×

Profitability

Gross margin33.1%-7.1pp

Operating margin-292.7%-553pp

Net margin-218.4%-781pp

FCF margin-1,073.3%—

Returns & leverage

Return on equity-35.2%+2.3pp

Debt / equity0×0.0×

Current ratio8.7×-8.3×

Where this comes from

Calculated from Perspective Therapeutics’s reported figures.

market cap/total stockholders equity=1.4×

Based on the most recent quarter.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Perspective Therapeutics's price / book?: Perspective Therapeutics (CATX) reported price / book of 1.4× in Q1 2026.
How has Perspective Therapeutics's price / book changed year-over-year?: Perspective Therapeutics's price / book increased by 146.8% year-over-year, from 0.6× to 1.4×.
What is the long-term trend for Perspective Therapeutics's price / book?: Over 5 years (2020 to 2025), Perspective Therapeutics's price / book has grown at a -19.5% compound annual growth rate (CAGR), from 2.9× to 1×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.